选择三阴性乳腺癌患者进行免疫治疗
Stephanie Downs-Canner1, Elizabeth A Mittendorf2
1Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA. Electronic address: https://twitter.com/SDownsCanner.
Surgical oncology clinics of North America
|September 15, 2023
概括
术前免疫疗法与化疗相结合,为早期三阴性乳腺癌提供了一种新的治疗方法. 精心选择患者至关重要,以管理风险并最大限度地获得益处,特别是与免疫相关的副作用.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 三重阴性乳腺癌 (TNBC) 提出了独特的治疗挑战.
- 早期的TNBC管理正在随着新的治疗策略而发展.
- 免疫疗法融入新辅助疗法是一个重要的发展.
研究的目的:
- 评估手术前免疫疗法和化疗在早期TNBC的影响.
- 为这种结合的新辅助方法定义最佳的患者选择标准.
- 突出管理免疫相关不良事件 (irAEs) 的重要性.
主要方法:
- 对临床试验数据和治疗指南的审查.
- 对新辅助免疫疗法加化疗患者结局的分析.
- 评估患者分层的风险益处概况.
主要成果:
- 术前免疫疗法与化疗相结合,代表了一项改变实践的进步.
- 有效的患者选择需要详细的分期和风险评估.
- 了解和管理IRE对于成功治疗至关重要.
结论:
- 术前免疫疗法和化疗的结合是TNBC早期阶段的重大进展.
- 谨慎的患者选择对于优化结果和安全至关重要.
- 与免疫相关的不良事件的积极管理是必不可少的.
相关概念视频
01:27Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K